ANDA 217094, held by Torrent Pharmaceuticals. Fluphenazine Hydrochloride.
As of Nov 21, 2026, ANDA 217094 (Fluphenazine Hydrochloride), held by Torrent Pharmaceuticals, was first approved by FDA on Jan 22, 2024, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 22, 2024 | Original application | Approved | None posted |
| Fluphenazine Hydrochloride1MG · tablet;oral | Fluphenazine Hydrochloride | Discontinued |
| Fluphenazine Hydrochloride2.5MG · tablet;oral | Fluphenazine Hydrochloride | Discontinued |
| Fluphenazine Hydrochloride5MG · tablet;oral | Fluphenazine Hydrochloride | Discontinued |
| Fluphenazine Hydrochloride10MG · tablet;oral | Fluphenazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters